H. Luo, X. Xia, G.D. Kim et al. Characterizing dedifferentiation of thyroid cancer by integrated analysis. Sci. Adv. 7(31), (2021). https://doi.org/10.1126/sciadv.abf3657
M.A. Zaballos, P. Santisteban, Key signaling pathways in thyroid cancer. J. Endocrinol. 235(2), R43–R61 (2017). /11// https://doi.org/10.1530/joe-17-0266
Article CAS PubMed Google Scholar
C.M. Kitahara, J.A. Sosa, The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 12(11), 646–653 (2016). https://doi.org/10.1038/nrendo.2016.110
A. Safavi, F. Azizi, R. Jafari et al. Thyroid cancer epidemiology in iran: a time trend study. Asian Pac. J. Cancer Prev. 17(1), 407–412 (2016). https://doi.org/10.7314/apjcp.2016.17.1.407
C. Liu, Q. Zhao, Z. Li et al. Mixed subtype thyroid cancer: a surveillance, epidemiology, and end results database analysis. Oncotarget 8(49), 86556–86565 (2017). https://doi.org/10.18632/oncotarget.21242
Article PubMed PubMed Central Google Scholar
M. Fiore, G. Oliveri Conti, R. Caltabiano et al. Role of emerging environmental risk factors in thyroid cancer: a brief review. 16(7), 1185 (2019). https://doi.org/10.3390/ijerph16071185
Y. Liu, L. Su, H. Xiao, Review of factors related to the thyroid cancer epidemic. Int. J. Endocrinol. 2017, 5308635 (2017). https://doi.org/10.1155/2017/5308635
Article CAS PubMed PubMed Central Google Scholar
Y. Wang, W. Wang. Increasing incidence of thyroid cancer in Shanghai, China, 1983–2007. 27(2), NP223–NP229 (2015). https://doi.org/10.1177/1010539512436874
J.J. Figge. Epidemiology of thyroid cancer. in Thyroid Cancer: A Comprehensive Guide to Clinical Management, eds. by L. Wartofsky, D. Van Nostrand (Springer, New York, 2016), p. 9–15
C.D. Seib, J.A. Sosa, Evolving understanding of the epidemiology of thyroid cancer. Endocrinol. Metab. Clin. North Am. 48(1), 23–35 (2019). https://doi.org/10.1016/j.ecl.2018.10.002
A. Matrone, F. Ferrari, F. Santini et al. Obesity as a risk factor for thyroid cancer. 27(5), 358–363 (2020). https://doi.org/10.1097/med.0000000000000556
S. Vaccarella, L. Dal Maso, Challenges in investigating risk factors for thyroid cancer. Lancet Diabetes Endocrinol. 9(2), 57–59 (2021). /2//10.1016/s2213-8587(20)30426-5
S. MU, I. KD, Modern diagnostic approachкеtreatment of thyroid cancer. Int. J. Dev. Public Policy 1(4), 101–105 (2021)
M. Pizzato, M. Li, J. Vignat et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. 10(4), 264–272 (2022)
H.A. Vahedian Ardakani, M. Moghimi, M. Shayestehpour et al. Survival of patients with thyroid cancer in Yazd, Iran. Asian Pac. J. Cancer Prev. 18(8), 2293–2297 (2017). https://doi.org/10.22034/apjcp.2017.18.8.2293
A. Bikas, K.D. Burman. Epidemiology of thyroid cancer. The Thyroid and its Diseases (Springer, 2019), p. 541–547
K.J. Stansifer, J.F. Guynan, B.M. Wachal et al. Modifiable risk factors and thyroid cancer. Otolaryngol. Head. Neck Surg. 152(3), 432–437 (2014). https://doi.org/10.1177/0194599814564537
L. Du, Z. Zhao, R. Zheng et al. Epidemiology of thyroid cancer: incidence and mortality in China, 2015. Front. Oncol. 10, 1702 (2020). https://doi.org/10.3389/fonc.2020.01702
Article PubMed PubMed Central Google Scholar
M. Fiore, A. Cristaldi, V. Okatyeva et al. Dietary habits and thyroid cancer risk: a hospital-based case–control study in Sicily (South Italy). Food Chem. Toxicol. 146, 111778 (2020). https://doi.org/10.1016/j.fct.2020.111778. 2020/12/01/
Article CAS PubMed Google Scholar
S. Vaccarella, S. Franceschi, F. Bray et al. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagno sis. N. Engl. J. Med. 375(7), 614–617 (2016). https://doi.org/10.1056/NEJMp1604412
F. Khodamoradi, M. Ghoncheh, A. Mehri et al. Incidence, mortality, and risk factors of thyroid cancer in the world: a review. 5(2), 9 (2018)
J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. 22(6), 395–404 (2010). https://doi.org/10.1016/j.clon.2010.05.004
A. Zahedi, L. Bondaz, M. Rajaraman et al. Risk for thyroid cancer recurrence is higher in men than in women independent of disease stage at presentation. 30(6), 871–877 (2020)
B. Farhood, B. Raei, R. Malekzadeh et al. A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries. 23(1), 7–15 (2019). https://doi.org/10.5114/wo.2019.84112
S. Deshpande, A. van Asselt, F. Tomini et al. Preferred reporting items for systematic reviews and meta-analysis (PRISMA) checklist. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis: NIHR Journals Library (2013)
S. Hassanipour, H. Delam, M. Arab-Zozani et al. Survival rate of prostate cancer in Asian countries: a systematic review and meta-analysis. Ann. Global Health. 86(1), (2020)
E. Von Elm, D.G. Altman, M. Egger et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull. World Health Organ. 85, 867–872 (2007)
H.-A. Nikbakht, S. Hassanipour, L. Shojaie et al. Survival Rate of colorectal cancer in Eastern Mediterranean region countries: a systematic review and meta-analysis. Cancer Control 27(1), 1073274820964146 (2020)
Article PubMed PubMed Central Google Scholar
K.W. Jung, Y.J. Won, H.J. Kong et al. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res. Treat. 45(1), 1–14 (2013). https://doi.org/10.4143/crt.2013.45.1.1
Article CAS PubMed PubMed Central Google Scholar
K. Jung, Y. Won, H. Kong et al. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2011 [Article]. Cancer Res. Treat. 46(2), 109–123 (2014). https://doi.org/10.4143/crt.2014.46.2.109
Article PubMed PubMed Central Google Scholar
K.W. Jung, S. Park, H.J. Kong et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res. Treat. 43(1), 1–11 (2011). https://doi.org/10.4143/crt.2011.43.1.1
Article PubMed PubMed Central Google Scholar
K.W. Jung, S. Park, H.J. Kong et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res. Treat. 44(1), 11–24 (2012). https://doi.org/10.4143/crt.2012.44.1.11
Article PubMed PubMed Central Google Scholar
K.W. Jung, Y.J. Won, H.J. Kong et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res. Treat. 47(2), 127–141 (2015). https://doi.org/10.4143/crt.2015.060
Article CAS PubMed PubMed Central Google Scholar
C.M. Oh, Y.J. Won, K.W. Jung et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res. Treat. 48(2), 436–450 (2016). https://doi.org/10.4143/crt.2016.089
Article PubMed PubMed Central Google Scholar
K.W. Jung, Y.J. Won, C.M. Oh et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2014. Cancer Res. Treat. 49(2), 292–305 (2017). https://doi.org/10.4143/crt.2017.118
Article PubMed PubMed Central Google Scholar
K.W. Jung, Y.J. Won, H.J. Kong et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2016. Cancer Res. Treat. 51(2), 417–430 (2019). https://doi.org/10.4143/crt.2019.138
Article PubMed PubMed Central Google Scholar
S. Hong, Y.J. Won, Y.R. Park et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res. Treat. 52(2), 335–350 (2020). https://doi.org/10.4143/crt.2020.206
Article PubMed PubMed Central Google Scholar
S. Hong, Y.J. Won, J.J. Lee et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2018. Cancer Res. Treat. 53(2), 301–315 (2021). https://doi.org/10.4143/crt.2021.291
Article PubMed PubMed Central Google Scholar
M.J. Kang, Y.-J. Won, J.J. Lee et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res. Treat. Off. J. Korean Cancer Assoc. 54(2), 330 (2022)
K.W. Jung, Y.J. Won, H.J. Kong et al. Cancer statistics in Korea: incidence, mortality, survival,and prevalence in 2015. Cancer Res. Treat. 50(2), 303–316 (2018). https://doi.org/10.4143/crt.2018.143
Article PubMed PubMed Central Google Scholar
H.R. Shin, D.H. Lee, S.Y. Lee et al. Cancer survival in Busan, Republic of Korea, 1996-2001. IARC Sci. Publ. 162, 155–162 (2011)
Z.H. Woo, Y.C. Hong, W.C. Kim et al. Cancer survival in Incheon, Republic of Korea, 1997-2001. IARC Sci. Publ. 162, 163–169 (2011)
Y.O. Ahn, M.H. Shin, Cancer survival in Seoul, Republic of Korea, 1993–1997. IARC Sci. Publ. 162, 171–178 (2011)
H. Zeng, R. Zheng, Y. Guo et al. Cancer survival in China, 2003-2005: a population-based study. Int. J. Cancer 136(8), 1921–1930 (2015). https://doi.org/10.1002/ijc.29227
Article CAS PubMed Google Scholar
S.C. Law, O.W. Mang, Cancer survival in Hong Kong SAR, China, 1996-2001. IARC Sci. Publ. 162, 33–41 (2011)
J.G. Chen, H.Z. Chen, J. Zhu et al. Cancer survival in patients from a hospital-based cancer registry, China. J. Cancer 9(5), 851–860 (2018). https://doi.org/10.7150/jca.23039
Article PubMed PubMed Central Google Scholar
J.G. Chen, J. Zhu, Y.H. Zhang et al. Cancer survival in Qidong, China, 1992–2000. IARC Sci. Publ. 162, 43–53 (2011)
Y.B. Xiang, F. Jin, Y.T. Gao, Cancer survival in Shanghai, China, 1992–1995. IARC Sci. Publ. 162, 55–68 (2011)
F. Jin, Y.B. Xiang, Y.T. Gao, Cancer survival in Shanghai, People’s Republic of China. IARC Sci. Publ. 145, 37–50 (1998)
H. Xishan, K. Chen, H. Min et al. Cancer survival in Tianjin, China, 1991–1999. IARC Sci. Publ. 162, 69–84 (2011)
H. Zeng, W. Chen, R. Zheng et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob. Health 6(5), e555–e567 (2018)
Y. Li, L. Yu, J. Na et al. Survival of cancer patients in Northeast China: analysis of sampled cancers from population-based cancer registries. Cancer Res. Treat. 49(4), 1106–1113 (2017). https://doi.org/10.4143/crt.2016.613
留言 (0)